1.Food allergy knowledge, perception of food allergy labeling, and level of dietary practice: A comparison between children with and without food allergy experience.
Yongmi CHOI ; Seyoung JU ; Hyeja CHANG
Nutrition Research and Practice 2015;9(1):92-98
BACKGROUND/OBJECTIVES: The prevalence of food allergies in Korean children aged 6 to 12 years increased from 10.9% in 1995 to 12.6% in 2012 according to nationwide population studies. Treatment for food allergies is avoidance of allergenic-related foods and epinephrine auto-injector (EPI) for accidental allergic reactions. This study compared knowledge and perception of food allergy labeling and dietary practices of students. SUBJECTS/METHODS: The study was conducted with the fourth to sixth grade students from an elementary school in Yongin. A total of 437 response rate (95%) questionnaires were collected and statistically analyzed. RESULTS: The prevalence of food allergy among respondents was 19.7%, and the most common food allergy-related symptoms were urticaria, followed by itching, vomiting and nausea. Food allergens, other than 12 statutory food allergens, included cheese, cucumber, kiwi, melon, clam, green tea, walnut, grape, apricot and pineapple. Children with and without food allergy experience had a similar level of knowledge on food allergies. Children with food allergy experience thought that food allergy-related labeling on school menus was not clear or informative. CONCLUSION: To understand food allergies and prevent allergic reactions to school foodservice among children, schools must provide more concrete and customized food allergy education.
Allergens
;
Ananas
;
Bivalvia
;
Cheese
;
Child*
;
Cucurbitaceae
;
Education
;
Epinephrine
;
Food Hypersensitivity*
;
Gyeonggi-do
;
Humans
;
Hypersensitivity
;
Juglans
;
Nausea
;
Prevalence
;
Prunus armeniaca
;
Pruritus
;
Surveys and Questionnaires
;
Tea
;
Urticaria
;
Vitis
;
Vomiting
2.Enantiomeric characterization and structure elucidation of Otamixaban
Jian SHEN ; Jiping YANG ; Winfried HEYSE ; Harald SCHWEITZER ; Norbert NAGEL ; Doris ANDERT ; Chengyue ZHU ; Vincent MORRISON ; Tengman CHEN ; Zhicheng ZHAO ; Yongmi CHOI
Journal of Pharmaceutical Analysis 2014;(3):197-204
Otamixaban is a potent (Ki ? 0.5 nM) fXa inhibitor currently in late-stage clinical develop-ment at Sanofi for the management of acute coronary syndrome. Being unproductive in obtaining a suitable crystal of Otamixaban, the required enantiomeric characterization has been accomplished using vibrational circular dichroism (VCD) spectroscopy. Selected by a spectrum similarity index, the calculated spectra of several higher energy conformers were found to match well with the observed spectra. The characteristic IR bands of these conformers were also identified and attributed to the solvation effect. Combined with both the single crystal x-ray diffraction results for an intermediate and the proton NMR study, the absolute configuration of Otamixaban is unambiguously determined to be (R,R).